LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 57.45 | 21.74 | 5927 | 6023 | 0.9840 | 0.9960 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 59.42 | 21.74 | 6344 | 6125 | 1.0357 | 1.0086 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 59.42 | 21.74 | 6379 | 6125 | 1.0414 | 1.0100 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 59.42 | 21.74 | 6330 | 6125 | 1.0334 | 1.0081 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 59.42 | 21.74 | 6379 | 6125 | 1.0414 | 1.0100 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 62.39 | 21.74 | 6776 | 6112 | 1.1085 | 1.0255 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 62.39 | 21.74 | 6810 | 6112 | 1.1141 | 1.0267 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 62.39 | 21.74 | 6743 | 6112 | 1.1031 | 1.0243 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 62.39 | 21.74 | 6827 | 6112 | 1.1168 | 1.0274 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.36 | 21.74 | 7139 | 6191 | 1.1531 | 1.0353 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.36 | 21.74 | 7183 | 6191 | 1.1602 | 1.0368 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.36 | 21.74 | 7140 | 6191 | 1.1533 | 1.0353 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.36 | 21.74 | 7205 | 6191 | 1.1638 | 1.0376 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.33 | 21.74 | 7543 | 6235 | 1.2097 | 1.0472 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.33 | 21.74 | 7582 | 6235 | 1.2159 | 1.0485 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.33 | 21.74 | 7490 | 6235 | 1.2012 | 1.0454 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.33 | 21.74 | 7570 | 6235 | 1.2140 | 1.0481 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.30 | 21.74 | 7844 | 6244 | 1.2561 | 1.0566 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.30 | 21.74 | 7887 | 6244 | 1.2630 | 1.0580 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.30 | 21.74 | 7843 | 6244 | 1.2560 | 1.0566 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.30 | 21.74 | 7985 | 6244 | 1.2787 | 1.0611 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.27 | 21.74 | 8154 | 6201 | 1.3148 | 1.0682 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.27 | 21.74 | 8196 | 6201 | 1.3215 | 1.0695 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.27 | 21.74 | 8205 | 6201 | 1.3230 | 1.0698 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.27 | 21.74 | 8320 | 6201 | 1.3415 | 1.0734 | MN20160310_N01 | D12 |